These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5490660)

  • 1. The activated partial thromboplastin time in the control of heparin treatment.
    Hirsh J; O'Sullivan EF; Gallus AS; Martin M
    Australas Ann Med; 1970 Nov; 19(4):334-7. PubMed ID: 5490660
    [No Abstract]   [Full Text] [Related]  

  • 2. A modified whole blood partial thromboplastin test for the assessment of heparinization.
    Ray PK; Abbott D
    Can Med Assoc J; 1973 Jun; 108(12):1505-8. PubMed ID: 4714876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of heparin therapy in thromboembolism].
    Hiller E
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1367-70. PubMed ID: 4716792
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.
    Ts'ao CH; Galluzzo TS; Lo R; Peterson KG
    Am J Clin Pathol; 1979 Jan; 71(1):17-21. PubMed ID: 420167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified method for monitoring heparin therapy at the bedside: the activated whole blood clotting time.
    Forman WB; Bayer G
    Am J Hematol; 1981 Nov; 11(3):277-81. PubMed ID: 7315841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin lock-induced alterations in the activated partial thromboplastin time.
    O'Neill TJ; Tierney LM; Proulx RJ
    JAMA; 1974 Mar; 227(11):1297-8. PubMed ID: 4405979
    [No Abstract]   [Full Text] [Related]  

  • 11. The activated partial thromboplastin time as a control in heparin therapy.
    Harmeling JG; Cordray DR
    South Med J; 1967 Jun; 60(6):594-8. PubMed ID: 6024630
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro comparison of the thrombin time and activated partial thromboplastin time in the laboratory control of heparin therapy.
    Soloway HB; Cox SP
    Am J Clin Pathol; 1973 Nov; 60(5):648-50. PubMed ID: 4543085
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 14. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated partial thromboplastin time test in heparin therapy. A study.
    Simmons A; Cross DE
    Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the activated partial thromboplastin time in the control of heparin administration.
    Lenaham JG; Frye S; Phillips GE
    Clin Chem; 1966 May; 12(5):263-8. PubMed ID: 5944655
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of various activated partial thromboplastin reagents in the laboratory control of heparin therapy.
    Soloway HB; Cornett BM; Grayson JW
    Am J Clin Pathol; 1973 Apr; 59(4):587-90. PubMed ID: 4692989
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
    Bounameaux H; Marbet GA; Lämmle B; Eichlisberger R; Duckert F
    Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical comparison of the automated activated partial thromboplastin time and the clotting time in the regulation of heparin therapy.
    Colman RW; Oxley L; Giannusa P
    Am J Clin Pathol; 1970 Jun; 53(6):904-7. PubMed ID: 5504609
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of the partial thromboplastin time to the Lee-White coagulation time.
    MacAulay MA; Frisch CR; Klionsky BL
    Tech Bull Regist Med Technol; 1968 Aug; 38(8):223-7. PubMed ID: 5678598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.